Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025
Amicus Therapeutics (Nasdaq: FOLD), a patient-focused biotechnology company specializing in rare diseases, has announced its participation in two major investor conferences in March 2025:
- TD Cowen 45th Annual Health Care Conference in Boston, MA on March 4, 2025, at 9:50 a.m. ET
- Leerink Partners 2025 Global Healthcare Conference in Miami, FL on March 10, 2025, at 10:00 a.m. ET
Both presentations will be accessible via live audio webcast through the investors section of the Amicus Therapeutics corporate website. The company focuses on discovering, developing, and delivering innovative first- or best-in-class medicines for rare disease patients.
Amicus Therapeutics (Nasdaq: FOLD), un'azienda biotecnologica focalizzata sui pazienti e specializzata nelle malattie rare, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel marzo 2025:
- TD Cowen 45ª Conferenza Annuale sulla Salute a Boston, MA, il 4 marzo 2025, alle 9:50 a.m. ET
- Leerink Partners 2025 Conferenza Globale sulla Salute a Miami, FL, il 10 marzo 2025, alle 10:00 a.m. ET
Entrambe le presentazioni saranno accessibili tramite webcast audio dal vivo nella sezione investitori del sito web aziendale di Amicus Therapeutics. L'azienda si concentra sulla scoperta, sviluppo e fornitura di medicinali innovativi di prima o migliore classe per i pazienti affetti da malattie rare.
Amicus Therapeutics (Nasdaq: FOLD), una empresa biotecnológica centrada en el paciente y especializada en enfermedades raras, ha anunciado su participación en dos importantes conferencias para inversores en marzo de 2025:
- 45ª Conferencia Anual de Salud de TD Cowen en Boston, MA, el 4 de marzo de 2025, a las 9:50 a.m. ET
- Conferencia Global de Salud 2025 de Leerink Partners en Miami, FL, el 10 de marzo de 2025, a las 10:00 a.m. ET
Ambas presentaciones estarán disponibles a través de una transmisión de audio en vivo en la sección de inversores del sitio web corporativo de Amicus Therapeutics. La empresa se enfoca en descubrir, desarrollar y ofrecer medicamentos innovadores de primera o mejor clase para pacientes con enfermedades raras.
Amicus Therapeutics (Nasdaq: FOLD), 환자 중심의 희귀 질환 전문 생명공학 회사가 2025년 3월 두 개의 주요 투자자 회의에 참여한다고 발표했습니다:
- TD Cowen 제45회 연례 헬스케어 컨퍼런스가 매사추세츠주 보스턴에서 2025년 3월 4일 오전 9:50 (ET)
- Leerink Partners 2025 글로벌 헬스케어 컨퍼런스가 플로리다주 마이애미에서 2025년 3월 10일 오전 10:00 (ET)
두 발표는 Amicus Therapeutics 기업 웹사이트의 투자자 섹션을 통해 라이브 오디오 웹캐스트로 접근할 수 있습니다. 이 회사는 희귀 질환 환자를 위한 혁신적인 1세대 또는 최고 품질의 의약품을 발견하고 개발하며 제공하는 데 주력하고 있습니다.
Amicus Therapeutics (Nasdaq: FOLD), une entreprise biopharmaceutique axée sur le patient et spécialisée dans les maladies rares, a annoncé sa participation à deux grandes conférences pour investisseurs en mars 2025 :
- 45ème Conférence Annuelle sur la Santé de TD Cowen à Boston, MA, le 4 mars 2025, à 9h50 ET
- Conférence Mondiale sur la Santé 2025 de Leerink Partners à Miami, FL, le 10 mars 2025, à 10h00 ET
Les deux présentations seront accessibles par le biais d'un webcast audio en direct via la section investisseurs du site web d'Amicus Therapeutics. L'entreprise se concentre sur la découverte, le développement et la fourniture de médicaments innovants de première ou meilleure classe pour les patients atteints de maladies rares.
Amicus Therapeutics (Nasdaq: FOLD), ein patientenorientiertes Biotechnologieunternehmen, das sich auf seltene Krankheiten spezialisiert hat, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 angekündigt:
- 45. TD Cowen Jahrestagung zur Gesundheitsversorgung in Boston, MA, am 4. März 2025, um 9:50 Uhr ET
- Leerink Partners 2025 Globale Gesundheitskonferenz in Miami, FL, am 10. März 2025, um 10:00 Uhr ET
Beide Präsentationen werden über einen Live-Audio-Webcast im Investorenbereich der Unternehmenswebsite von Amicus Therapeutics zugänglich sein. Das Unternehmen konzentriert sich auf die Entdeckung, Entwicklung und Bereitstellung innovativer Medikamente der ersten oder besten Klasse für Patienten mit seltenen Krankheiten.
- None.
- None.
PRINCETON, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in March.
- TD Cowen 45th Annual Health Care Conference in Boston, MA, on Tuesday, March 4, 2025, at 9:50 a.m. ET
- Leerink Partners 2025 Global Healthcare Conference in Miami, FL, on Monday, March 10, 2025, at 10:00 a.m. ET
A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
FAQ
When and where will Amicus Therapeutics (FOLD) present at the TD Cowen Healthcare Conference in March 2025?
How can investors access Amicus Therapeutics (FOLD) March 2025 conference presentations?
What is the schedule for FOLD's presentation at the Leerink Partners Conference in March 2025?
What type of medicines does Amicus Therapeutics (FOLD) focus on developing?
